Vitamin A Oral Liquid Preparation DEFINITION Vitamin A Oral Liquid Preparation is an emulsion, suspension, or solution that contains retinyl acetate or retinyl palmitate in an amount equivalent to NLT 95.0% and NMT 120.0% of the labeled amount of vitamin A, as retinol (C20H30O). IDENTIFICATION [NoteUse low-actinic glassware. ] • A. Procedure Sample solution: Prepare a solution in methylene chloride containing an amount of Oral Liquid Preparation equivalent to about 6 µg of retinol in 1 mL. Analysis: Add 10 mL of antimony trichloride TS to 1 mL of Sample solution. Acceptance criteria: A transient blue color appears at once. • B. Thin-Layer Chromatographic Identification Test 201 Standard solution: 0.5 mg/mL of retinol from USP Retinyl Acetate RS or USP Retinyl Palmitate RS in methylene chloride Sample solution: Dissolve or extract with methylene chloride a quantity of Oral Liquid Preparation to obtain a solution with a nominal concentration of 0.5 mg/mL of retinol. Application volume: 10 µL as an 8-mm band Developing solvent system: A mixture of cyclohexane and ether (4:1) Spray reagent: 0.2 g/mL of phosphomolybdic acid in alcohol. Filter and use only the clear filtrate. Analysis: Apply the Sample solution at the starting point of the chromatogram, and proceed as directed for Chromatography 621, Thin-Layer Chromatography. Allow the solvent front to move 10 cm, remove the plate, and air-dry. Spray with Spray reagent. Acceptance criteria: The blue-green spot formed is indicative of the presence of retinol, and its RF value corresponds to that of the Standard solution. The approximate RF values of the predominant spots, corresponding to the different forms of retinol, are 0.1 for the alcohol form, 0.45 for the acetate, and 0.7 for the palmitate. ASSAY • Vitamin A [NoteUse low-actinic glassware. ] Standard solution 1: 13 µg/mL of retinol from USP Retinyl Acetate RS in n-hexane Standard solution 2: 13 µg/mL of retinol from USP Retinyl Palmitate RS in n-hexane System suitability solution: Mix equal volumes of Standard solution 1 and Standard solution 2. Sample solution For Oral Liquid Preparation in oil vehicles packaged in single-unit containers: Deliver the contents of NLT 30 single-unit containers, following the directions for use as stated in the labeling. Weigh directly the individual contents delivered from each single-unit container, and calculate the average. [NoteDo not weigh the contents delivered by difference between full containers and empty containers. Capsules intended as single-unit containers are not rinsed after expulsion of the contents. ] Mix the contents to obtain a homogeneous sample. Transfer an amount of the composite to a suitable volumetric flask; dissolve it with hexane, and dilute with hexane quantitatively and stepwise, if necessary, to obtain a solution containing the equivalent of about 13 µg/mL of retinol, based on the labeled amount. For Oral Liquid Preparation in oil vehicles packaged in multiple-unit containers: Dissolve an accurately measured volume of Oral Liquid Preparation in a suitable volume of hexane, and dilute with hexane, quantitatively and stepwise, if necessary, to obtain a solution containing the equivalent to about 13 µg/mL of retinol, based on the labeled amount. For Oral Liquid Preparation in aqueous vehicles: Transfer a mass, or an accurately measured volume of Oral Liquid Preparation, into a separatory funnel, and extract quantitatively with hexane or other suitable solvent. Dilute with hexane, quantitatively and stepwise, if necessary, to obtain a solution containing the equivalent of about 13 µg/mL of retinol, based on the labeled amount. Chromatographic system Mode: LC Detector: UV 325 nm Column: 4.6-mm × 15-cm; packing L8 Flow rate: 1 mL/min Injection size: 40 µL System suitability Sample: System suitability solution Suitability requirements Resolution: NLT 10 between all-trans-retinyl acetate and all-trans-retinyl palmitate Relative standard deviation: NMT 3.0% Analysis Samples: Standard solution 1 or Standard solution 2 and Sample solution Calculate the percentage of the labeled amount of vitamin A, as retinol (C20H30O), in each individual container: Result = (rU/rS) × (C/W) × (V/D) × U × (100/L)
Acceptance criteria: 95.0%120.0% PERFORMANCE TESTS • Deliverable Volume 698 For Oral Liquid Preparation packaged in multiple-unit containers: Meets the requirements • Uniformity of Dosage Units 905 For Oral Liquid Preparation packaged in single-unit containers: Empty the single-unit containers, following the directions for use as stated in the labeling. The contents so delivered, and weighed directly, meet the requirements. [NoteDo not weigh the contents delivered by difference between full containers and empty containers. Capsules intended for use as single-unit containers are not rinsed after expulsion of the contents. ] ADDITIONAL REQUIREMENTS • Packaging and Storage: Preserve in tight, light-resistant containers. It may be packaged in single-unit containers. [NoteCapsules may be suitable as single-unit containers provided they are packaged in critical secondary containers as described in Good Packaging Practices 1177. ] • Labeling: The label states that the product is Vitamin A Oral Liquid Preparation. Label the Oral Liquid Preparation to indicate the ester form in which the vitamin is present, and to indicate the amount of vitamin A delivered in each dosage unit in terms of the equivalent amount of retinol in mg/dosage unit. The amount of vitamin A delivered may be stated also in USP Units/dosage unit, on the basis that 1 USP Vitamin A Unit equals the biological activity of 0.3 µg of all-trans-retinol. Capsules used as single-unit containers may be exempted from the requirements of individual labeling, provided they are packaged in an appropriately labeled secondary container, including directions for use and delivery of each dosage unit of Oral Liquid Preparation. Label the Oral Liquid Preparation packaged in multiple-unit containers to indicate the volume of each dosage unit. Auxiliary Information Please check for your question in the FAQs before contacting USP.
USP35NF30 Page 5030 Pharmacopeial Forum: Volume No. 35(3) Page 596Chromatographic Column Chromatographic columns text is not derived from, and not part of, USP 35 or NF 30. |